Efficacy of ipilimumab 3mg/kg following progression on low dose ipilimumab in metastatic melanoma.

被引：0
|
作者：
Lai-Kwon, Julia Elizabeth
Jacques, Sarah
Carlino, Matteo S.
Benannoune, Naima
Robert, Caroline
Allayous, Clara
Baroudjian, Barouyr
Lebbe, Celeste
Zimmer, Lisa
Eroglu, Zeynep
Topcu, Turkan Ozturk
Dimitriou, Florentia
Haydon, Andrew Mark
Lo, Serigne N.
Menzies, Alexander M.
Long, Georgina V.
机构：
[1] Melanoma Inst Australia, Wollstonecraft, Australia
[2] Crown Princess Mary Canc Ctr, Sydney, NSW, Australia
[3] Blacktown Hosp, Blacktown, Australia
[4] Gustave Roussy, Canc Campus, Villejuif, France
[5] Gustave Roussy, Villejuif, France
[6] Paris Saclay Univ, Paris, France
[7] Hop St Louis, AP HP, Dermatol Dept, Paris, France
[8] St Louis Hosp, AP HP, Dept Dermatol, Paris, France
[9] Univ Paris, Hop St Louis, AP HP, Paris, France
[10] Univ Hosp Essen, Dept Dermatol, Essen, Germany
[11] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[12] H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, Tampa, FL USA
[13] Univ Zurich Hosp, Zurich, Switzerland
[14] Alfred Hosp, Melbourne, Vic, Australia
[15] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia
[16] Royal North Shore & Mater Hosp, Sydney, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21533
引用
收藏
页数：1
相关论文
共 50 条
  • [41] IPILIMUMAB IN PRETREATED METASTATIC UVEAL MELANOMA PATIENTS: SAFETY AND CLINICAL EFFICACY
    Danielli, Riccardo
    Queirolo, Paola
    Testori, Alessandro
    Plummer, Ruth
    Razis, Evangelia
    Sileni, Vanna Chiarion
    Calabro, Luana
    Di Giacomo, Anna Maria
    Ridolfi, Ruggero
    Maio, Michele
    ANNALS OF ONCOLOGY, 2009, 20
  • [42] Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy
    Danielli, Riccardo
    Ridolfi, Ruggero
    Chiarion-Sileni, Vanna
    Queirolo, Paola
    Testori, Alessandro
    Plummer, Ruth
    Boitano, Monica
    Calabro, Luana
    De Rossi, Costanza
    Di Giacomo, Anna Maria
    Ferrucci, Pier Francesco
    Ridolfi, Laura
    Altomonte, Maresa
    Miracco, Clelia
    Balestrazzi, Angelo
    Maio, Michele
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (01) : 41 - 48
  • [43] Ipilimumab in pretreated metastatic uveal melanoma patients: safety and clinical efficacy
    Danielli, R.
    Queirolo, P.
    Testori, A.
    Plummer, R.
    Razi, E.
    Sileni, V. Chiarion
    Calabro, L.
    Di Giacomo, A. M.
    Ridolfi, R.
    Maio, M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 581 - 581
  • [44] Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy
    Riccardo Danielli
    Ruggero Ridolfi
    Vanna Chiarion-Sileni
    Paola Queirolo
    Alessandro Testori
    Ruth Plummer
    Monica Boitano
    Luana Calabrò
    Costanza De Rossi
    Anna Maria Di Giacomo
    Pier Francesco Ferrucci
    Laura Ridolfi
    Maresa Altomonte
    Clelia Miracco
    Angelo Balestrazzi
    Michele Maio
    Cancer Immunology, Immunotherapy, 2012, 61 : 41 - 48
  • [45] Bilateral neuroretinitis and anterior uveitis following ipilimumab treatment for metastatic melanoma
    Hahn L.
    Pepple K.L.
    Journal of Ophthalmic Inflammation and Infection, 6 (1)
  • [46] Eosinophilic Pneumonia Following Treatment with Nivolumab-Ipilimumab for Metastatic Melanoma
    Wajda, N. A.
    Pina, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [47] Clinical and immunologic variables associated with outcomes following combination ipilimumab and nivolumab immunotherapy in melanoma.
    Rosner, Samuel
    Kwong, Erica
    Panageas, Katherine
    Postow, Michael Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [48] Multicenter phase I/II trial of encorafenib with and without binimetinib in combination with nivolumab and low-dose ipilimumab in metastatic BRAF-mutant melanoma.
    Jameson-Lee, Max
    Ott, Patrick Alexander
    Luke, Jason J.
    Postow, Michael A.
    Poklepovic, Andrew Stewart
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [49] Phase 1 study to evaluate safety and efficacy of ipilimumab plus nivolumab plus external beam radiotherapy in patients with metastatic melanoma.
    Postow, Michael Andrew
    Knox, Susan Jane
    McCabe, Danielle
    Macri, Mary J.
    Schwarzenberger, Paul
    Ricciardi, Toni
    Ryan, Aileen
    Venhaus, Ralph Rudolph
    Barker, Christopher Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [50] High dose ipilimumab (Ipi) plus temozolomide (TMZ) after progression on standard or low dose Ipi in advanced melanoma
    Williamson, Julie
    Fadlullah, Muhammad Zaki Hidayatullah
    Kovacsovics, Magdalena
    Gibson, Berit
    Erickson-Wayman, Alyssa
    Jamison, Debra
    Sageser, Daniel S.
    Swami, Umang
    Jeter, Joanne M.
    Bowles, Tawnya Lynn
    Cannon, Donald Maurice
    Ben Haaland
    Schroeder, Joyce
    McPherson, Jordan P.
    Hyngstrom, John Robert
    Tan, Aik-choon
    Hu-Lieskovan, Siwen
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345